Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/12/030107
CTRI/2020/12/030107
Active, not recruiting
Phase 4

A COMPARATIVE STUDY TO INVESTIGATE THE EFFECT OF VAMANA KARMA AND TRIPHALA AND GUDUCHI CHURNA WITH MADHU ON GUT MICROBIOTA AND METABOLITE PATTERNS IN PRAMEHA W.S.R TO TYPE 2 DIABETES MELLITUS AND HEALTHY INDIVIDUALS.

All India Institute of Ayurveda0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Ayurveda
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •For Prameha(Type 2 Diabetes Mellitus) Individuals\-
  • •1\. BMIââ?°Â¥ 20
  • •2\. Kaphaj/Kapha\-pittaj Vikriti predominant individuals
  • •3\. Diagnosed cases of Prameha/Madhumeha/T2DM with either of the following\-
  • •a) Fasting plasma glucose values of ââ?°Â¥ 7\.0 mmol/L (126 mg/dl)
  • •b) 2\-h post\-load plasma glucose ââ?°Â¥ 11\.1 mmol/L (200 mg/dl)
  • •c) HbA1c ââ?°Â¥ 6\.5% (48 mmol/mol)
  • •d) Random blood glucose ââ?°Â¥ 11\.1 mmol/L (200 mg/dl)
  • •4\. Chronicity: Up to 10 years
  • •For Healthy Individuals

Exclusion Criteria

  • •Patients unfit for Snehana(Internal Oleation), Svedana(Sudation), Vamana(therapeutically induced emesis for internal bio\-cleansing).
  • •For Prameha(Type 2 Diabetes Mellitus)\-
  • •1\. Patients with T2 DM exceeding the following plasma glucose limits\-
  • •a) Fasting plasma glucose values of ââ?°Â¥ 300mg/dL
  • •b) 2\-h post\-load plasma glucoseââ?°Â¥400mg/dL
  • •c) Random blood glucoseââ?°Â¥ 400mg/dL
  • •2\. Chronicity: More than 10 years.
  • •3\. Known cases of Severe systemic diseases like\- Cardiac disease, pulmonary tuberculosis, severe lung disease, uncontrolled diabetes and pregnant women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Medicated Enema And Virechan Karma Along With Shamana Therapy In The Management Of Post Chikungunya Chronic Inflammatory RheumatismHealth Condition 1: - Health Condition 2: M064- Inflammatory polyarthropathy
CTRI/2020/06/025754Institute For Post Graduate Training And Research In Ayurveda
Not yet recruiting
Phase 2
a clinial study to evaluate the the effect of purgation with Trivritadi kwath and drug effect with avipattikar churna in the management of Heart Burning in Acidity.Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
CTRI/2019/09/021295Choudhary brahm prakash charak ayurveda sansthana
Completed
Not Applicable
Efficacy of Virechana and Shamana Yoga in Polycystic Ovarian Syndrome
CTRI/2020/08/027424Principal RGGPG Ayurvedic College and Hospital Paprola40
Not yet recruiting
Not Applicable
TO COMPARE THE EFFECT OF TWO AYURVEDA MEDICINE IN MANAGEMENT OF INFANTILE COLIC
CTRI/2020/10/028643Sri Dharmasthala Manjunatheswara college of ayurveda and hospital Hassan Thannirhallah Hassan
Completed
Not Applicable
Prospective observational study on the impact of vaccination against COVID-19 among National Cancer Center staff.none
JPRN-UMIN000049430ational cancer center209